No Data
No Data
Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy
This Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday
Aclaris Therapeutics Raised to Buy From Neutral by HC Wainwright & Co.
Aclaris Therapeutics Analyst Ratings
H.C. Wainwright Upgrades Aclaris Therapeutics(ACRS.US) to Buy Rating, Announces Target Price $20
Express News | Aclaris Therapeutics Inc : H.c. Wainwright Raises to Buy From Neutral